MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)

||
||

Cash Flow Overview

Change in Cash
$218,950K
Free Cash flow
-$33,145K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from april 2026 offerin...
    • Proceeds from maturities of mark...
    • Accrued expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Net loss
    • Prepaid expenses and other curre...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-41,206
-31,820
-29,583
-30,277
Stock-based compensation expense
7,284
6,968
4,115
10,165
Net accretion of premiums and discounts on marketable securities
955
446
663
1,040
Non-cash lease expense
149
143
139
319
Depreciation expense
43
43
28
20
Prepaid expenses and other current assets
4,643
-461
805
2,402
Other non-current assets
25
-
0
0
Accounts payable
4,288
-493
1,947
-2,456
Accrued expenses and other current liabilities
5,062
-1,304
2,207
4,806
Operating lease liability
-138
-125
20
-439
Related party accounts payable and other current liabilities
-3,004
2,995
1
-111
Net cash used in operating activities
-33,145
-23,578
-22,594
-21,602
Purchases of property and equipment
0
73
63
99
Purchases of marketable securities
490,547
90,834
100,987
267,683
Proceeds from maturities of marketable securities
79,600
76,470
79,028
145,333
Net cash (used in) provided by investing activities
-410,947
-14,437
-22,022
-122,449
Proceeds from april 2026 offering, net of offering costs
-658,336
-
-
-
Proceeds from the pipe financings, net
-
-
-264
169,908
Proceeds from at-the-market offering, net of commissions
0
38,902
-
-
Proceeds from issuance of common stock upon exercise of stock options and employee warrants
4,369
1,698
562
0
Proceeds from issuance of common stock under employee stock purchase plan
337
-
-
-
Net cash provided by financing activities
663,042
40,600
298
169,908
Net increase in cash and cash equivalents
218,950
2,585
-44,318
25,857
Cash and cash equivalents at beginning of period
49,520
46,935
91,253
61,575
Cash and cash equivalents at end of period
268,470
49,520
46,935
91,253
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

ORKA Cash Flow Sankey DiagramSankey diagram visualizing ORKA cash flow for the periodProceeds from april 2026offering, net of offering...-$658,336K Proceeds from issuance ofcommon stock upon...$4,369K (3908.26%↑ Y/Y)Proceeds from issuance ofcommon stock under...$337K Net cash provided byfinancing activities$663,042K (608195.41%↑ Y/Y)Net increase in cashand cash...$218,950K (5630.18%↑ Y/Y)Canceled cashflow$444,092K Proceeds from maturitiesof marketable...$79,600K (-60.21%↓ Y/Y)Stock-based compensationexpense$7,284K (-26.87%↓ Y/Y)Accrued expenses andother current...$5,062K (2081.90%↑ Y/Y)Accounts payable$4,288K (256.74%↑ Y/Y)Non-cash lease expense$149K (-20.32%↓ Y/Y)Depreciation expense$43K (22.86%↑ Y/Y)Net cash (used in)provided by investing...-$410,947K (-961.05%↓ Y/Y)Net cash used inoperating activities-$33,145K (24.69%↑ Y/Y)Canceled cashflow$79,600K Canceled cashflow$16,826K Purchases of marketablesecurities$490,547K (222.12%↑ Y/Y)Net loss-$41,206K (9.58%↑ Y/Y)Prepaid expenses andother current assets$4,643K (506.93%↑ Y/Y)Related party accountspayable and other...-$3,004K (49.11%↑ Y/Y)Net accretion ofpremiums and discounts on...$955K (-71.06%↓ Y/Y)Operating lease liability-$138K (-375.86%↓ Y/Y)Other non-currentassets$25K (-58.33%↓ Y/Y)